AIG
MRTX

American International Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

American International Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-450
Closed -$26.4K – 3041
2023
Q4 		$26.4K Buy
450
+65
+17% +$3.65K ﹤0.01% 2938
2023
Q3 		$16.8K Sell
385
-22
-5% -$786 ﹤0.01% 2999
2023
Q2 		$14.7K Sell
407
-42
-9% -$1.73K ﹤0.01% 3032
2023
Q1 		$16.7K Sell
449
-10
-2% -$450 ﹤0.01% 2913
2022
Q4 		$20.8K Buy
459
+8
+2% +$518 ﹤0.01% 2920
2022
Q3 		$31K Buy
451
+1
+0.2% +$74 ﹤0.01% 2928
2022
Q2 		$30K Sell
450
-286
-39% -$18.2K ﹤0.01% 2971
2022
Q1 		$61K Sell
736
-2
-0.3% -$205 ﹤0.01% 2784
2021
Q4 		$108K Buy
738
+22
+3% +$3.42K ﹤0.01% 2682
2021
Q3 		$127K Sell
716
-57
-7% -$9.17K ﹤0.01% 2681
2021
Q2 		$125 Sell
773
-25,468
-97% -$4.09M ﹤0.01% 2787
2021
Q1 		$4.5K Sell
26,241
-106
-0.4% -$21K 0.02% 863
2020
Q4 		$5.79K Buy
26,347
+3,909
+17% +$845K 0.02% 716
2020
Q3 		$3.73M Sell
22,438
-46
-0.2% -$6.29K 0.02% 782
2020
Q2 		$2.57M Buy
22,484
+4,879
+28% +$473K 0.01% 879
2020
Q1 		$1.35M Buy
17,605
+549
+3% +$49.2K 0.01% 998
2019
Q4 		$2.2M Sell
17,056
-144
-0.8% -$13.9K 0.01% 967
2019
Q3 		$1.34M Buy
17,200
+1,313
+8% +$123K 0.01% 1147
2019
Q2 		$1.64M Buy
15,887
+2,223
+16% +$173K 0.01% 1088
2019
Q1 		$1M Buy
13,664
+383
+3% +$26.1K ﹤0.01% 1318
2018
Q4 		$563K Sell
13,281
-100
-0.7% -$3.98K ﹤0.01% 1596
2018
Q3 		$630K Buy
13,381
+1,582
+13% +$88.1K ﹤0.01% 1743
2018
Q2 		$582K Buy
+11,799
New +$446K ﹤0.01% 1732
2017
Q2 		– Sell
-7,928
Closed -$41K – 3133
2017
Q1 		$41K Buy
7,928
+629
+9% +$3.45K ﹤0.01% 2879
2016
Q4 		$35K Sell
7,299
-20
-0.3% -$109 ﹤0.01% 2918
2016
Q3 		$48.4K Buy
7,319
+11
+0.2% +$59 ﹤0.01% 2900
2016
Q2 		$39.9K Buy
7,308
+476
+7% +$7.59K ﹤0.01% 2993
2016
Q1 		$146K Hold
6,832
– – ﹤0.01% 3073
2015
Q4 		$216K Buy
6,832
+990
+17% +$35K ﹤0.01% 2761
2015
Q3 		$201K Buy
5,842
+6
+0.1% +$181 ﹤0.01% 2830
2015
Q2 		$184K Buy
5,836
+1,325
+29% +$39K ﹤0.01% 3089
2015
Q1 		$132K Hold
4,511
– – ﹤0.01% 3344
2014
Q4 		$83.5K Sell
4,511
-179
-4% -$3.02K ﹤0.01% 3723
2014
Q3 		$82.1K Sell
4,690
-3
-0.1% -$56 ﹤0.01% 3705
2014
Q2 		$93.9K Buy
+4,693
New +$90.6K ﹤0.01% 3634

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

American International Group's MRTX Position: Q1 2024 in Review

American International Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 450 shares — an estimated $26.4K sold.

American International Group first reported a position in MRTX in Q2 2014 and held it in 35 quarters. The position peaked at $3.73M in Q3 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • American International Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • American International Group sold 450 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $26.4K.
  • American International Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and held it in 35 quarters.
  • American International Group's Mirati Therapeutics, Inc. Common Stock position peaked at $3.73M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on American International Group's 13F filing for Q1 2024, filed 13 May 2024.